Methadone titration in opioid-resistant cancer pain

European Journal of Cancer Care

Volumn 8, Issue 1, 1999, Pages 26-29

  Scholes, Carol F ^a   Gonty, N ^a   Trotman, I F ^a  

^a MOUNT VERNON HOSPITAL   (United Kingdom)

Author keywords

Analgesia; Cancer pain; Cross tolerance; Methadone; Opioid

Indexed keywords

METHADONE; MORPHINE; NARCOTIC ANALGESIC AGENT;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; DRUG ADMINISTRATION; DRUG RESISTANCE; DRUG TOLERANCE; FEMALE; HUMAN; MALE; MIDDLE AGED; NEOPLASM; ORAL DRUG ADMINISTRATION; PAIN; PAIN ASSESSMENT; PHARMACOKINETICS;

ADMINISTRATION, ORAL; ADULT; AGED; AGED, 80 AND OVER; ANALGESICS, OPIOID; DRUG ADMINISTRATION SCHEDULE; DRUG RESISTANCE; DRUG TOLERANCE; FEMALE; HUMANS; MALE; METHADONE; MIDDLE AGED; MORPHINE; NEOPLASMS; PAIN; PAIN MEASUREMENT; THERAPEUTIC EQUIVALENCY;

EID: 0033085148     PISSN: 09615423     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2354.1999.00133.x     Document Type: Article

References (18)

1. Beaver W.T., Wallenstein S.L., Houde R.W. et al (1967) A clinical comparison of the analgesic effects of methadone and morphine administered intramuscularly, and of oral and parenterally administered methadone. Clinical Pharmacology and Therapy 8, 415-426.
2. Crews J.C., Sweeny N.J. & Denson D.D. (1993) Clinical efficacy of methadone in patients refractory to other mu-receptor agonist analgesics for management of terminal cancer pain. Cancer 72, 2266-2272.
3. De Conno F., Groff L.O., Brunelli C. et al (1996) Clinical experience with oral methadone administration in the treatment of pain in 196 advanced cancer patients. Journal of Clinical Oncology 14, 2836-2842.
4. De Stoutz N.D., Bruera E. & Suarez-Almazor M. (1995) Opioid rotation for toxicity reduction in terminal cancer patients. Journal of Pain Symptom Management 10, 378-384.
5. Ebert B., Andersen S. & Krogsgaard-Larsen P. (1995) Ketobemidone, methadone and pethidine are non-competitive N-methyl-D-aspartate (NMDA) antagonists in the rat cortex and spinal cord. Neuroscience Letters 187, 165-168.
6. Faisinger R., Schoeller T. & Bruera E. (1993) Methadone in the management of cancer pain: a review. Pain 52, 137-147.
7. Hunt G. & Bruera E. (1995) Respiratory depression in a patient receiving oral methadone for cancer pain. Journal of Pain Symptom Management 10, 401-404.
8. Inturrisi C.E., Colhurn W.A., Kaiko R.F. et al. (1987) Pharmacokinetics and pharmacodynamics of methadone in patients with chronic pain. Clinical Pharmacology Therapy 41, 392-401.
9. Kolesnikov Y.A., Pick C.G. & Pasternak G.W. (1992) Ng-nitro-L arginine prevents morphine tolerance. European Journal of Pharmacology 221, 399-400.
10. Mercadante S., Sapio M., Serretta R. et al. (1996) Patient-controlled analgesia with oral methadone in cancer pain: preliminary report. Annual Oncology 7, 613-617.
11. Morley J.S., Watt J.W.G., Wells J.C. et al (1993) Methadone in pain uncontrolled by morphine (letter). Lancet 342, 1243.
12. Rogers A.G. (1988) The use of methadone in opioid-tolerant patients. Journal of Pain Symptom Management 3, 45.
13. Sukiennik A.W. & Kream R.M. (1995) N-methyl-D-asparate (NMDA) receptors and pain. Current Opinion on Anaesthesia 8, 445-449.
14. Thomas Z. & Bruera E. (1995) Use of a methadone in a highly tolerant patient receiving parenteral hydromorphone. Journal of Pain Symptom Management 10, 315-317.
15. Tiseo P.J. & Inturrisi C.E. (1993) Attenuation and reversal of morphine tolerance by the competitive N-methyl-D-aspartate receptor antagonist, LY274614. Journal of Pharmacological Experiment Therapy 264, 1090-1096.
16. Twycross R.G. (1977) A comparison of diamorphine-with-cocaine and methadone. British Journal of Pharmacology 4, 691-693.
17. Watanabe S., Belzile M., Kuehn N. et al (1996) Capsules and suppositories of methadone for patients on high-dose opioids for cancer pain: clinical and economic considerations. Cancer Treatment Review 22, 131-136.
18. World Health Organisation (1996) Cancer Pain Relief, 2nd edn. World Health Organisation, Geneva.